Jeff Bornstein

Jeffrey Bornstein serves as the Chief Medical Officer at Mediar Therapeutics since July 2023, bringing extensive leadership experience from previous roles, including Chief Medical Officer at Eledon Pharmaceuticals, Inc. from April 2021 to July 2023 and Vice President, Head of Clinical Sciences at Takeda from January 2017 to April 2021. Additional positions include Senior Medical Director at Biogen Idec, Sr. Director of Clinical Research at Gilead Sciences, VP of Clinical Development at Ocera Therapeutics, and Vice President at Tioga Pharmaceuticals. Early career experience includes a role as Director at Elan and Assistant Professor at Duke University Medical Center. Jeffrey Bornstein completed a Fellowship in Gastroenterology/Hepatology at Duke University and holds a Doctor of Medicine (MD) from McGill University.